Dundee, United Kingdom

Christopher Meades

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Cyclacel Limited, Cyclacel Limted. Active years: 2008-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Meades. Retrieved from https://idiyas.com/inventor/christopher-meades

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 20.0


Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Inventive Journey of Christopher Meades: A Maestro of Patents in Dundee, GB

Introduction:

Christopher Meades, a distinguished inventor hailing from Dundee, GB, has made significant strides in the realm of patent innovation with a portfolio boasting 5 unique patents.

Latest Patents:

1. "Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy": This patent encompasses compounds essential for treating various disorders such as proliferative disorders, viral disorders, CNS disorders, stroke, alopecia, and diabetes.

2. "Pyrimidine compounds": Meades' patent focuses on substituted pyrimidines as inhibitors of cyclin-dependent kinases (CDKs), hence proving beneficial in the treatment of proliferative and viral disorders.

Career Highlights:

Meades has left an indelible mark on companies like Cyclacel Limited and Cyclacel Limited, steering the trajectory of innovation in the pharmaceutical domain through his groundbreaking patents.

Collaborations:

Throughout his professional journey, Meades has had the privilege of collaborating with accomplished individuals such as Shudong Wang and Gavin Wood, further amplifying the impact of his inventive endeavors.

Conclusion:

In conclusion, Christopher Meades stands as a beacon of innovation, reshaping the landscape of pharmaceutical advancements with his inventive zeal and unwavering commitment to revolutionizing therapy and treatment modalities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…